scholarly article | Q13442814 |
P50 | author | Felipe V. Gomes | Q47705373 |
P2093 | author name string | Anthony A Grace | |
David W Volk | |||
Jessica R Edelson | |||
P2860 | cites work | Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning | Q24650912 |
Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. | Q24681363 | ||
Translating the MAM model of psychosis to humans | Q26860217 | ||
Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types | Q28262858 | ||
Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? | Q28279719 | ||
Cortical inhibitory neurons and schizophrenia | Q29547683 | ||
The adolescent brain and age-related behavioral manifestations | Q29618654 | ||
A neurobehavioral systems analysis of adult rats exposed to methylazoxymethanol acetate on E17: implications for the neuropathology of schizophrenia | Q30465716 | ||
Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia | Q30494823 | ||
Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. | Q30497212 | ||
CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum | Q31817073 | ||
Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia | Q33932087 | ||
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses | Q33940688 | ||
Schizophrenia as a disorder of developmentally reduced synaptic connectivity | Q33965926 | ||
Schizophrenia: an integrated sociodevelopmental-cognitive model | Q34023115 | ||
Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. | Q34214883 | ||
Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor | Q34245130 | ||
Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic/associative and sensorimotor cortical areas | Q34300051 | ||
Developmental trajectory of the endocannabinoid system in human dorsolateral prefrontal cortex | Q34350080 | ||
Meta-analysis of the Association Between the Level of Cannabis Use and Risk of Psychosis. | Q34514461 | ||
Neurodevelopment, GABA system dysfunction, and schizophrenia | Q34675943 | ||
Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction | Q35044627 | ||
Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia | Q35612878 | ||
CB1 Cannabinoid Receptor Expression in the Striatum: Association with Corticostriatal Circuits and Developmental Regulation | Q35820005 | ||
Postnatal development of prefrontal inhibitory circuits and the pathophysiology of cognitive dysfunction in schizophrenia | Q35835597 | ||
Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and Schizophrenia | Q35990574 | ||
Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders | Q36499391 | ||
Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations | Q36618870 | ||
Rethinking schizophrenia in the context of normal neurodevelopment | Q36844622 | ||
A loss of parvalbumin-containing interneurons is associated with diminished oscillatory activity in an animal model of schizophrenia | Q37369353 | ||
Synapse formation and regression in the cortex during adolescence and in schizophrenia | Q37394104 | ||
Striatal Neurons Expressing D1 and D2 Receptors are Morphologically Distinct and Differently Affected by Dopamine Denervation in Mice | Q37609566 | ||
Disturbed synaptic connectivity in schizophrenia: convergence of genetic risk factors during neurodevelopment | Q37740262 | ||
Corticostriatal circuitry | Q38805959 | ||
Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model | Q38846609 | ||
CB1 cannabinoid receptor stimulation during adolescence impairs the maturation of GABA function in the adult rat prefrontal cortex | Q38959085 | ||
Hardwiring the brain: endocannabinoids shape neuronal connectivity | Q39798626 | ||
Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors. | Q42520647 | ||
Immunodensity and mRNA expression of A2A adenosine, D2 dopamine, and CB1 cannabinoid receptors in postmortem frontal cortex of subjects with schizophrenia: effect of antipsychotic treatment | Q43299005 | ||
Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. | Q44741537 | ||
Adolescent environmental enrichment prevents the emergence of schizophrenia-like abnormalities in a neurodevelopmental model of schizophrenia | Q47365827 | ||
Gamma oscillations correlate with working memory load in humans | Q48146164 | ||
Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia. | Q48481384 | ||
The Circuitry of Dopamine System Regulation and its Disruption in Schizophrenia: Insights Into Treatment and Prevention. | Q49551829 | ||
Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. | Q51976878 | ||
Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. | Q52030475 | ||
Schizophrenia | Q56959104 | ||
P921 | main subject | schizophrenia | Q41112 |
P304 | page(s) | 254-260 | |
P577 | publication date | 2018-04-26 | |
P1433 | published in | Schizophrenia Research | Q7431607 |
P1476 | title | Altered brain cannabinoid 1 receptor mRNA expression across postnatal development in the MAM model of schizophrenia | |
P478 | volume | 201 |
Search more.